A PHASE 2, OPEN-LABEL, MULTI-CENTER STUDY OF AL101 (BMS-906024) IN PATIENTS WITH ADENOID CYSTIC CARCINOMA (ACC) BEARING ACTIVATING NOTCH MUTATIONS

Registry ID

AL-ACC-01

Source registry

HEALTH_CANADA

Status

Closed

Phase

PHASE2

Study type

INTERVENTIONAL

Sponsor

AYALA PHARMACEUTICALS, INC.

Start date

2020-04-17

Completion date

2022-07-15

Last update

2018-09-28

Conditions

• ADENOID CYSTIC CARCINOMA (ACC)

Related clinical trials

• A PHASE 1A/1B, FIRST-IN-HUMAN, MULTICENTER STUDY TO ASSESS THE EFFICACY AND SAFETY OF RGT-61159 FOR TREATMENT OF PATIENTS WITH RELAPSED/REFRACTORY ADENOID CYSTIC CARCINOMA (ACC) OR COLORECTAL CARCINOMA (CRC)

View on source registry